Neurodevelopmental follow-up at 36 months' corrected age of preterm infants treated with prophylactic indomethacin

Archives of Pediatrics and Adolescent Medicine

Volumn 154, Issue 6, 2000, Pages 598-602

  Couser, Robert J ^a   Hoekstra, Ronald E ^a   Ferrara, T Bruce ^a   Wright, Gregory B ^a   Cabalka, Allison K ^a   Connett, John E ^b  

^a CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN BLOOD FLOW; BRAIN DEVELOPMENT; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; HUMAN; INFANT; MAJOR CLINICAL STUDY; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL;

EID: 0034090095     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.154.6.598     Document Type: Article

References (23)

1. Krovetz LJ, Rowe RD. Patent ductus, prematurity and pulmonary disease. N Engl J Med. 1972;287:513-514.
2. Thibeault DW, Emmanouilides GC, Nelson RJ, Lachman RS, Rosengart RM, Oh W. Patent ductus arteriosus complicating the respiratory distress syndrome in preterm infants. J Pediatr. 1975;86:120-126.
3. Alpan G, Clyman RI. Cardiovascular effects of surfactant replacement with special reference to the patent ductus arteriosus. In: Robertson B, Taeusch HW, eds. Surfactant Therapy for Lung Disease: Lung Biology in Health and Disease. Vol 84. New York, NY: Marcel/Dekker: 1995:531-545.
4. Couser RJ, Ferrara TB, Wright GB, et al. Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room. J Pediatr. 1996;128:631-637.
5. Domanico RS, Waldman JD, Lester LA, McPhillips HA, Catrambone JE, Covert RF. Prophylactic indomethacin reduces the incidence of pulmonary hemorrhage and patent ductus arteriosus in surfactant-treated infants <1250 grams [abstract]. Pediatr Res. 1994;35:331A.
6. Ment LR, Oh W, Ehrenkranz RA, et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics. 1994; 93:543-550.
7. Fowlie PW. Prophylactic indomethacin: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 1996;74:F81-F87.
8. Van Be F, Van de Bor M, Stijnen T, Baan J, Ruys JH. Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: duration of its effect. Pediatrics. 1989;84:802-807.
9. Leffler CW, Busija DW, Fletcher AM, Beasley DG, Hessler JR, Green RS. Effects of indomethacin upon cerebral hemodynamics of newborn pigs. Pediatr Res. 1985; 19:1160-1164.
10. McCormick DC, Edwards AD, Brown GC, et al. Effect of indomethacin on cerebral oxidized cytochrome oxidase in preterm infants. Pediatr Res. 1993;33:603-608.
11. Avery GB, Fletcher AB, Kaplan, Brudno DS. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics. 1985; 75:106-111.
12. Yaffe SJ, Friedmann WF, Rogers D, et al. The disposition of indomethacin in premature babies. J Pediatr. 1980;97:1001-1006.
13. Papile LS, Burstein J, Burstein R, et al. Incidence and evolution of the subependymal intraventricular hemorrhage: a study of infants with weights less than 1500 grams. J Pediatr. 1978;92:529-534.
14. Allan WC, Philip AGS. Neonatal cerebral pathology diagnosed by ultrasound. Clin Perinatol. 1985;12:195-216.
15. Northover BJ. Indomethacin: a calcium antagonist. Gen Pharmacol. 1983;8:293-296.
16. Dahlgren N, Nilsson B, Sakabe T, et al. The effect of indomethacin on cerebral blood flow and oxygen consumption in the rat at normal and increased carbon dioxide tensions. Acta Physiol Scand. 1982;III:475-485.
17. Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med. 1976; 295:530-535.
18. Mardourn R, Bejar R, Merritt TA, Berry C. Controlled study of the effects of indomethacin on cerebral blood flow velocities in newborn infants. J Pediatr. 1991; 118:112-115.
19. Edwards AD, Wyatt JS, Richardson C, et al. Effects of indomethacin on cerebral haemodynamics in very preterm infants. Lancet. 1990;335:1491-1495.
20. Ment LR, Stewart WB, Scott DT, Duncan CC. Beagle puppy model of intraventricular hemorrhage: randomized indomethacin prevention trial. Neurology. 1983; 33:179-184.
21. Ment LR, Stewart WB, Ardito TA, Huang E, Madri JA. Indomethacin promotes germinal matrix microvessel maturation in the newborn beagle pup. Stroke. 1992; 23:1132-1137.
22. Ment LR, Vohr B, Oh W, et al. Neurodevelopmental outcome at 36 months' corrected age of preterm infants in the Multicenter Indomethacin intraventricular Hemorrhage Prevention Trial. Pediatrics. 1996;98:714-718.
23. Clyman RI. Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies. J Pediatr. 1996;128:631-637.